Table 2.
Single site | Two sites (increase cervical site) | p-value | Two sites (increase forearm) | p-value | Two sites (increase thigh) | p-value | Two sites (increase leg) | p-value | |
---|---|---|---|---|---|---|---|---|---|
Positive ratio | Cervical 66.7% (61/90) |
Cervical x 290.5% (19/21) | 0.037* | Cervical/forearm68.4% (13/19) | 0.956* | Cervical/thigh75% (18/24) | 0.496 | Cervical/leg80% (72/90) | 0.062 |
Leg 42.2% (38/90) |
Leg/cervical80% (72/90) | <0.001* | Leg/forearm52.6% (10/19) | 0.406 | Leg/thigh45.8% (11/24) | 0.751 | – | ||
Thigh 33.3 (8/24) |
Thigh/cervical75% (18/24) | 0.004* | – | – | – | – | Thigh/leg45.8% (11/24) | 0.376 | |
Forearm 21.1% (4/19) |
Forearm/cervical68.4% (13/19) | 0.003* | – | – | – | – | Forearm/leg52.6% (10/19) | 0.044* | |
p-value | <0.001* | 0.521 | 0.265 | 0.039* | 0.001* |
p < 0.05.